Harbor Investment Advisory’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.99K Hold
1,658
﹤0.01% 1057
2026
Q1
$3.78K Hold
1,658
﹤0.01% 1056
2025
Q4
$6.63K Hold
1,658
﹤0.01% 1010
2025
Q3
$14K Sell
1,658
-400
-19% -$3.88K ﹤0.01% 847
2025
Q2
$23.2K Hold
2,058
﹤0.01% 764
2025
Q1
$19.5K Hold
2,058
﹤0.01% 770
2024
Q4
$23.2K Hold
2,058
﹤0.01% 731
2024
Q3
$58.2K Hold
2,058
0.01% 568
2024
Q2
$39.3K Hold
2,058
﹤0.01% 623
2024
Q1
$67.5K Hold
2,058
0.01% 523
2023
Q4
$68K Hold
2,058
0.01% 501
2023
Q3
$56K Hold
2,058
0.01% 526
2023
Q2
$62.4K Hold
2,058
0.01% 644
2023
Q1
$66.8K Hold
2,058
0.01% 621
2022
Q4
$57.8K Hold
2,058
0.01% 659
2022
Q3
$74K Hold
2,058
0.01% 549
2022
Q2
$63K Sell
2,058
-200
-9% -$5.83K 0.01% 628
2022
Q1
$73K Hold
2,258
0.01% 625
2021
Q4
$62K Hold
2,258
0.01% 676
2021
Q3
$70K Hold
2,258
0.01% 625
2021
Q2
$48K Hold
2,258
0.01% 714
2021
Q1
$46K Sell
2,258
-300
-12% -$5.71K 0.01% 698
2020
Q4
$41K Hold
2,558
0.01% 679
2020
Q3
$32K Sell
2,558
-350
-12% -$4.12K 0.01% 617
2020
Q2
$21K Hold
2,908
﹤0.01% 618
2020
Q1
$16K Sell
2,908
-205
-7% -$1.83K ﹤0.01% 617
2019
Q4
$28K Buy
+3,113
New +$25.3K 0.01% 499

Other funds holding EVH

Harbor Investment Advisory's EVH Position: Q2 2026 in Review

Harbor Investment Advisory held its Evolent Health (EVH) position steady in Q2 2026 at 1,658 shares worth $8.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

Harbor Investment Advisory first reported a position in EVH in Q4 2019 and has held it in 27 quarters since. The position peaked at $74K in Q3 2022. 13 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Harbor Investment Advisory held 1,658 shares of Evolent Health worth $8.99K as of Q2 2026.
  • Harbor Investment Advisory left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1057 holding.
  • Harbor Investment Advisory first reported a position in Evolent Health in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Evolent Health position peaked at $74K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.